SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
1-Year Return
18.59%
This Quarter Return
+5.7%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.45B
AUM Growth
+$79.5M
(+3.4%)
Cap. Flow
+$225M
Cap. Flow
% of AUM
9.17%
Top 10 Holdings %
Top 10 Hldgs %
45.17%
Holding
110
New
9
Increased
23
Reduced
22
Closed
11
Top Buys
| 1 |
UnitedHealth
UNH
|
$74.5M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$41.6M |
| 3 |
Biohaven
BHVN
|
$41.5M |
| 4 |
Apple
AAPL
|
$39.3M |
| 5 |
Sysco
SYY
|
$37.2M |
Top Sells
| 1 |
argenx
ARGX
|
$48M |
| 2 |
Cigna
CI
|
$43.7M |
| 3 |
McKesson
MCK
|
$32M |
| 4 |
Verizon
VZ
|
$23.5M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$22.8M |
Sector Composition
| 1 | Healthcare | 65.51% |
| 2 | Technology | 11.21% |
| 3 | Communication Services | 6.91% |
| 4 | Consumer Discretionary | 6.1% |
| 5 | Financials | 3.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Oracle
ORCL
$623B
| $34.6M | 1.27% |
245,114
+48,440
| +25% | +$6.84M |
|
27
GE Aerospace
GE
$298B
| $32.6M | 1.2% |
204,957
-54,974
| -21% | -$8.74M |
|
28
Erasca
ERAS
$406M
| $32.5M | 1.19% |
+13,768,039
| New | +$32.5M |
|
29
CRH
CRH
$74.5B
| $32.4M | 1.19% |
431,984
+96,404
| +29% | +$7.23M |
|
30
ArriVent BioPharma
AVBP
$770M
| $31.8M | 1.17% |
1,712,703
+148,994
| +10% | +$2.76M |
|
31
McDonald's
MCD
$228B
| $28.1M | 1.03% |
+110,434
| New | +$28.1M |
|
32
Ferguson
FERG
$47.4B
| $28.1M | 1.03% |
145,040
-24,240
| -14% | -$4.69M |
|
33
Tesla
TSLA
$1.08T
| $26.7M | 0.98% |
+134,913
| New | +$26.7M |
|
|
34
Verizon
VZ
$186B
| $25.2M | 0.92% |
609,904
-569,548
| -48% | -$23.5M |
|
35
Chipotle Mexican Grill
CMG
$55.6B
| $25M | 0.92% |
398,500
| – | – |
|
36
PepGen
PEPG
$40.7M
| $24.3M | 0.89% |
1,520,932
| – | – |
|
37
ProKidney
PROK
$309M
| $23M | 0.84% |
9,341,266
+5,473,419
| +142% | +$13.5M |
|
38
Sutro Biopharma
STRO
$81.8M
| $22.6M | 0.83% |
7,708,690
+1,930,502
| +33% | +$5.66M |
|
39
Boston Scientific
BSX
$160B
| $19.4M | 0.71% |
251,689
-51,346
| -17% | -$3.95M |
|
40
Pinterest
PINS
$25.2B
| $18.1M | 0.66% |
409,951
+14,100
| +4% | +$621K |
|
41
Zura Bio
ZURA
$129M
| $17M | 0.63% |
4,860,939
+2,010,939
| +71% | +$7.04M |
|
42
Fulcrum Therapeutics
FULC
$349M
| $15.8M | 0.58% |
2,541,046
-307,440
| -11% | -$1.91M |
|
43
Abeona Therapeutics
ABEO
$348M
| $15.6M | 0.57% |
+3,685,503
| New | +$15.6M |
|
44
Arcus Biosciences
RCUS
$1.23B
| $14.6M | 0.54% |
957,304
| – | – |
|
45
Johnson & Johnson
JNJ
$429B
| $13.2M | 0.48% |
90,097
| – | – |
|
46
Benitec Biopharma
BNTC
$365M
| $11.8M | 0.43% |
1,691,290
+1,487,070
| +728% | +$10.4M |
|
47
Immatics
IMTX
$648M
| $11M | 0.4% |
946,563
| – | – |
|
48
Sanofi
SNY
$112B
| $10.2M | 0.38% |
210,701
| – | – |
|
49
InflaRx
IFRX
$105M
| $9.98M | 0.37% |
5,733,910
| – | – |
|
50
Monte Rosa Therapeutics
GLUE
$300M
| $9.94M | 0.37% |
+2,659,000
| New | +$9.94M |
|